NMRD
Closed
Nemaura Medical Inc
0.0001
0.0000 (0.00%)
Last Update: 01 Jul 2025 16:30:00
Yesterday: 0.0001
Day's Range: 0.0001 - 0.0001
Send
sign up or login to leave a comment!
When Written:
0.8497
Nemaura Medical Inc. is a medical technology company that develops and commercializes non-invasive diagnostic and monitoring devices. The company's flagship product is the sugarBEAT, a continuous glucose monitoring system that allows individuals with diabetes to monitor their glucose levels in real-time without the need for finger pricks. The sugarBEAT is a small, wearable patch that is placed on the skin and uses a disposable sensor to measure glucose levels in the interstitial fluid.
Nemaura Medical Inc. is headquartered in Loughborough, United Kingdom, and has offices in the United States and India. The company's mission is to improve the lives of people with diabetes by providing them with innovative and affordable solutions for glucose monitoring.
In addition to the sugarBEAT, Nemaura Medical Inc. is also developing a range of other non-invasive diagnostic and monitoring devices, including a lactate monitoring system for athletes and a sleep monitoring system for sleep apnea. The company has partnerships with several major healthcare companies and is actively pursuing regulatory approval for its products in the United States and other markets around the world.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Nemaura Medical Inc. is headquartered in Loughborough, United Kingdom, and has offices in the United States and India. The company's mission is to improve the lives of people with diabetes by providing them with innovative and affordable solutions for glucose monitoring.
In addition to the sugarBEAT, Nemaura Medical Inc. is also developing a range of other non-invasive diagnostic and monitoring devices, including a lactate monitoring system for athletes and a sleep monitoring system for sleep apnea. The company has partnerships with several major healthcare companies and is actively pursuing regulatory approval for its products in the United States and other markets around the world.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








